产品名称
Monoamine Oxidase (MAO) Inhibitor Screening Kit, sufficient for 100 fluorometric tests
application(s)
pharmaceutical
detection method
fluorometric
relevant disease(s)
Alzheimer′s disease; Parkinson′s disease; depression; migraine disorder; schizophrenia; substance abuse; neurodegenerative disorders; neuropsychiatric diseases; neurological disorders
shipped in
wet ice
storage temp.
−20°C
Quality Level
Application
The kit is suitable for inhibitor screening and evaluation of MAO inhibitors.
Biochem/physiol Actions
The Monoamine Oxidase (MAO) Inhibitor Screening Kit provides a convenient fluorometric means to screen for MAO enzyme inhibitors. In the assay, MAO reacts with p-tyramine, a substrate for both MAO-A and MAO-B, resulting in the formation of H2O2, which is determined by a fluorometric method at λEx = 530 nm/λEm = 585 nm.
Features and Benefits
- Compatible with high-throughput handling systems.
General description
Monoamine oxidases (MAO) are a family of mitochondrial enzymes that catalyze the oxidative deamination of monoamines. Two isoforms of MAO exist, MAO-A and MAO-B, with different inhibitor selectivity and tissue distribution. MAO dysfunction is thought to be responsible for a number of neurological disorders. Unusually high or low levels of MAOs in the body have been associated with depression, schizophrenia, substance abuse, attention deficit disorder, migraines, and irregular sexual maturation. MAO inhibitors are one of the major classes of drug prescribed for the treatment of depression, Parkinson′s, and Alzheimer′s diseases.
存储类别
10 - Combustible liquids
wgk
WGK 2
法规信息
含少量动物源组分生物产品
此项目有
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持